Skip to content Skip to footer

TOP 20

Women Health Focusing Top 20 2024
Top 20 Women Health Focusing Companies of 2024 Based on Market Cap
Shots: While the World celebrated International Women’s Day, PharmaShots was busy preparing an exciting report on the Top 20 Women Health Focusing Companies Based on Market Cap Women's Health Market size was valued at $38.10B in 2023 and is expected to register $58.10B by 2030 with a CAGR of 4.9 percent. AbbVie managed to secure…
Radiopharma Based on Market Cap Top 20 2024
Top 20 Radiopharma Companies of 2024 Based on Market Cap
Shots: With diverse applications in diagnostic imaging, theragnostics, and targeted therapy, radiopharmaceuticals are gradually tapping into an ocean of unlimited opportunities By 2030, the radiopharmaceutical market size is expected to grow to $12.18B. In 2023, POINT Biopharma topped the list among radiopharma companies with a market cap of $726.88B followed by Novartis with a market…
Life Sciences Deals Top 20 2023
Top 20 Life Sciences Deals of 2023 by Total Deal Value
Shots:  Driven by mutual growth and expansion, strategic collaborations are embedded deeply in the modus operandi of life sciences deals. In 2023, the volume of life science deals was comparatively high vs. 2022  The collaboration deal between Daiichi Sankyo and Merck & Co. for $22B ranks first in our list followed by the development and…
Biopharma M&A Top 20 2023
Top 20 Biopharma M&A of 2023 by Total Deal Value
Shots: With stringent antitrust regulation clasping the overall volume of M&A deals, the biopharma industry manages to hold up a few strong M&A while conquering the waves of unexpected economic turmoil in 2023 In 2023, the global biopharma industry witnessed an astounding transformation with M&A deals. Pfizer’s acquisition of Seagen for $43B ranks first in…
Animal Health Based Top 20 2022
Top 20 Animal Health Companies Based on 2022 Total Revenue
Shots: The animal health industry is involved in a wide variety of services, from disease prevention to addressing insatiable nutritional needs. This sector not only protects us from potential zoonotic diseases but also delivers food of high quality derived from animals In 2022, the animal health industry was valued at $58.66B. By 2030, the global animal health…
Contract Development and Manufacturing Organizations Top 20 2022
20 Contract Development and Manufacturing Organizations (CDMOs) of 2022
Shots: Over the years, CDMOs have significantly transformed the course of pharmaceutical and biopharmaceutical companies by leveraging their flexible manufacturing facilities and on-time drug deliveries CDMOs help meet the ever-evolving needs of the healthcare sector by fostering the use of new-age technologies and advanced drug development and manufacturing processes PharmaShots brings a condensed report on 20 Contract…
Prescription Drugs Based Top 20 2022
Top 20 Prescription Drugs Based on 2022 Total Revenue
Shots: Prescription drugs have an instrumental role in effectively controlling chronic diseases like heart-related conditions, diabetes, arthritis, hypertension, and cancer, among others. Unlike over-the-counter drugs, prescription drugs are advised not to be taken without the authorization of a doctor In 2022, the global market size of prescription drugs was worth $1035.5B and is envisioned to…
Countries in Healthcare Innovation Top 20 2022
Top 20 Countries in Healthcare Innovation
Shots:  PharmaShots unravels the determinants of healthcare innovation with this rigorously prepared report on the Top 20 Countries in Healthcare Innovation. A meticulous report that encompasses all the significant aspects, necessary for well-rounded and innovative growth in the healthcare industry for a country  By deploying extensive market research, PharmaShots gathered, evaluated, organized, and analyzed the…
Generics Pharma Top 20 2021
Top 20 Generics Pharma Companies Based on 2022 Revenue
Shots:  Safe, reliable, efficacious, and most importantly cost-effective, it won’t be wrong to ascribe generic drugs as the advocate for health equity. Generic drugs have indispensably aided the healthcare needs of developing and under-developed countries  In 2022, the global market size of generic drugs was valued at $411.99B and is envisioned to reach $613.34B by…
Monoclonal Antibodies Based Top 20 2022
Top 20 Monoclonal Antibodies Based on 2022 Total Revenue 
Shots: Monoclonal antibodies are transforming therapeutics through their highly efficient targeting mechanisms. There is a wide range of uses for monoclonal antibodies, including diagnosis, therapy, and research In 2021, the monoclonal antibody therapy market size was valued at $178.5B and is envisioned to reach $451.89B by 2028, displaying a CAGR of 14.1%. Humira was the…

Sign Up to Our Newsletter

Be the first to know the latest updates

[mc4wp_form id="13387" element_id="style-1"]